alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
***CERTIFICATION      PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED***

***PURSUANT      TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002***

|   | (1) | The                Report fully complies with the requirements of Section 13(a) or 15(d)                of                the Securities Exchange Act of 1934;                and |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | The                information contained in the Report fairly presents, in all material                respects, the financial condition and results of operations of the                Company. |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                                                                                                                                                                                                                                                                                              |   |   |   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|--------|
| /s/ Mark                Klein                                                                                                                                                                                                                                                                |   |   |   |
| Name: Mark                KleinTitle:                 Chief                Executive Officer, President and Director                (Principal Executive Officer and Principal                Financial                and Accounting Officer) August                18, 2006 |   |   |   |

----
* Pursuant to Local Rule 47.5, the court has determined

that this opinion should not be published and is not precedent except under the limited circumstances set forth in Local Rule 47.5.4. IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 96-40069 Conference Calendar

TERRY D. SMITH, Plaintiff-Appellant,

versus JAMES BRADSHAW, Proprietor, Bradshaw State Jail; J.C. Conner, Warden, Bradshaw State Jail; BRADSHAW STATE JAIL, Defendants-Appellees.

- - - - - - - - - - Appeal from the United States District Court for the Eastern District of Texas USDC No. 6:95-CV-663

- - - - - - - - - - June 26, 1996 Before HIGGINBOTHAM, BARKSDALE, and BENAVIDES, Circuit Judges.
PER CURIAM: * Terry D. Smith, Texas prisoner #713234, appeals from the magistrate judge’s dismissal of his 42 U.S.C. § 1983 action as frivolous under 28 U.S.C. § 1915(d). Smith argues that the magistrate judge abused her discretion in dismissing his § 1983 action as appellees allowed an argument to escalate and did notNo. 96-40069 - 2 - stop an attack on Smith by other inmates. Because Smith did not allege that the appellees were aware of a known threat or a substantial risk of serious harm, the magistrate judge did not abuse her discretion in dismissing Smith’s failure-to-protect claim as frivolous under § 1915(d). Farmer v. Brennan , 114 S. Ct. 1970, 1976 (1994); Jacquez v. Procunier , 801 F.2d 789, 792 (5th Cir. 1986). Smith also argues that appellees were deliberately indifferent to his serious medical needs as they failed to provide adequate medical care after the inmate attack. Because Smith’s allegations amount to no more than negligence or medical malpractice, the magistrate judge did not abuse her discretion in dismissing Smith’s lack-of-adequate-medical-care claim as frivolous under § 1915(d). See Varnado v. Lynaugh , 920 F.2d 320, 321 (5th Cir. 1991). Smith’s appeal is without factual or legal basis and is thus frivolous. See Howard v. King , 707 F.2d 215, 219-20 (5th Cir. 1983). Accordingly, his appeal is DISMISSED AS FRIVOLOUS. 5th Cir. R. 42.2. We caution Smith that any additional frivolous appeals filed by him or on his behalf will invite the imposition of sanctions. To avoid sanctions, Smith is further cautioned to review any pending appeals to ensure that they do not raise arguments that are frivolous because they have been previously decided by this court.
APPEAL DISMISSED; SANCTION WARNING ISSUED.
Shawn BERDUX v. ALTAPOINTE HEALTH SYSTEMS, INC.

1160007

Supreme Court of Alabama.

July 7, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
EXHIBIT
32.2


CERTIFICATION
PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002


(18
U.S.C. SECTION 1350)





In
connection with the accompanying Quarterly Report of OmniReliant Holdings Inc.
(the “Company”) on Form 10-Q for the period ended March 31, 2009 (the “Report”),
I, Paul Morrison, Chief Financial Officer of the Company, hereby certify that to
my knowledge:





(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and





(2) The
information contained in the Report fairly presents, in all material respects,
the consolidated financial condition and results of operations of the
Company.





Date:
      May 20,
      2009
                  By:
                  /s/ Paul
      MorrisonPaul
      MorrisonChief
      Financial
Officer
CARR STONE, INC. v. Masha SHAD, Wife of/and Darius Shad and Ron Vaccaro Construction Company, Inc.

NO. 2019-C-0131

Supreme Court of Louisiana.

March 18, 2019

*95Denied.
# C_2019172EN.01002401.xml

| 20.5.2019 | EN | Official Journal of the European Union | C 172/24 |
| --- | --- | --- | --- |

20.5.2019

EN

Official Journal of the European Union

C 172/24

---

Order of the President of the First Chamber of the Court of 13 February 2019 (request for a preliminary ruling from the Conseil d’État — France) — Japan Tobacco International SA, Japan Tobacco International France SAS v Premier ministre, Ministre de l’Action et des Comptes publics, Ministre des Solidarités et de la Santé

(Case C-569/17) (1)

(2019/C 172/29)

Language of the case: French

The President of the First Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 437, 18.12.2017.

---
Case 3:05-cv-00526-R Document 9 Filed 07/06/05 Page 1 of 1 PageID 85
# C_2017249EN.01001701.xml

| 31.7.2017 | EN | Official Journal of the European Union | C 249/17 |
| --- | --- | --- | --- |

31.7.2017

EN

Official Journal of the European Union

C 249/17

---

Request for a preliminary ruling from the Corte suprema di cassazione (Italy) lodged on 20 March 2017 — Catia Passeri v Fondazione Teatro dell’Opera di Roma

(Case C-143/17)

(2017/C 249/26)

Language of the case: Italian

Referring court

Corte suprema di cassazione

Parties to the main proceedings

Appellant: Catia Passeri

Respondent: Fondazione Teatro dell’Opera di Roma

Question referred

Are the provisions of national law in Article 3(7) of Decree Law No 64 of 30 April 2010, converted into Law No 100 of 29 June 2010, according to which ‘
  for workers in the performing arts belonging to the category of dancers, the retirement age is fixed for men and women at the forty-fifth year of chronological age, with the use, for workers to whom the contributory or mixed system applies in full, of the transformation coefficient referred to in Article 1(6) of the Law of 8 August 1995, No 335, relative to the higher age. For the two years following the date of entry into force of this provision, the workers referred to in this paragraph employed on contracts of indefinite duration, who have reached or passed the retirement age, are afforded the option, renewable annually, of remaining in service. This option must be exercised through a formal application to be presented to the ENPALS within two months of the date of entry into force of this provision, or at least three months before pension rights are fully vested, without prejudice to the maximum retirement age of forty-seven years for women and fifty-two for men
  ’, contrary to the principle of non-discrimination on grounds of sex, laid down in Directive 2006/54 (1) and in the Charter of Fundamental Rights of the European Union (Article 21)?

---

(1)  Directive 2006/54/EC of the European Parliament and of the Council of 5 July 2006 on the implementation of the principle of equal opportunities and equal treatment of men and women in matters of employment and occupation (recast) (OJ 2006 L 204, p. 23).

---
Exhibit
      13.2





PRINCIPAL FINANCIAL OFFICERCERTIFICATION


PURSUANT TO 18 U.S.C. SECTION 1350







In connection with this Annual ReportofGolden State Petro (IOM 1-A) PLC(the “Company”) on Form
20-F for the annual period ended December 31, 2007, as filed with
the Securities and Exchange Commission (the “SEC”) on or about
the date hereof (the “Report”), I, Kate Blankenship, the PrincipalFinancial Officer of the Company, certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:







(1)
            The Report fully complies with the requirements of
      Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
  and





(2)
            The information contained in the Report fairly
      presents, in all material respects, the financial condition and results of
      operations of the Company.





A signed original of this written statement has been
provided to the Companyand will be
retained by the Company and furnished to the SEC or its staff upon
request.







Date:  June 30, 2008









/s/  Kate
Blankenship




KateBlankenship


Principal Financial Officer
```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 659 Introduced in House (IH)]

113th CONGRESS
  2d Session
H. RES. 659

  Amending the Rules of the House of Representatives to prohibit the 
    Committee on Ethics from waiving any requirement that Members, 
      officers, and employees of the House include information on 
  reimbursements for travel in the financial disclosure reports such 
individuals are required to file under the Ethics in Government Act of 
                                 1978.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              July 8, 2014

  Mr. Loebsack (for himself, Mr. Fitzpatrick, Mr. Braley of Iowa, Mr. 
Enyart, Mr. Walz, Mrs. Bustos, Mr. Cohen, Mr. Quigley, Mr. Cooper, Mr. 
McDermott, Mr. Ruiz, Mr. Barrow of Georgia, Mr. Nolan, Ms. Tsongas, Ms. 
Shea-Porter, and Mr. Foster) submitted the following resolution; which 
                 was referred to the Committee on Rules

_______________________________________________________________________

                               RESOLUTION

 
  Amending the Rules of the House of Representatives to prohibit the 
    Committee on Ethics from waiving any requirement that Members, 
      officers, and employees of the House include information on 
  reimbursements for travel in the financial disclosure reports such 
individuals are required to file under the Ethics in Government Act of 
                                 1978.

    Resolved,

SECTION 1. PROHIBITING WAIVER OF REQUIREMENT TO INCLUDE TRAVEL 
              INFORMATION IN FINANCIAL DISCLOSURE REPORTS OF MEMBERS, 
              OFFICERS, AND EMPLOYEES OF THE HOUSE.

    Clause 5 of rule XXV of the Rules of the House of Representatives 
is amended by adding at the end the following new paragraph:
    ``(j) The Committee on Ethics may not use its authority under this 
clause or section 111(2) of the Ethics in Government Act of 1978 (5 
U.S.C. App. 112(2)) to waive any requirement under title I of such Act 
that Members, Delegates, Resident Commissioners, officers, or employees 
include information on reimbursements for travel (as described in 
section 102(a)(2)(B) of such Act) in the reports such individuals are 
required to file under title I of such Act.''.
                                 <all>
```
**Exhibit 31.1**

**CERTIFICATIONS**

I, Jane E. Shaw,certify that:

1.      I have reviewed this annual report on Form 10-K ofAerogen, Inc.;

2.                 Based on myknowledge, this annual report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statementsmade, in light of the circumstances in which such statements were made, notmisleading with respect to the period covered by this annual report;

3*.**                *Basedon my knowledge, the financial statements, and other financial informationincluded in this annual report, fairly present in all material respects thefinancial condition, results of operations and cash flows of the registrant asof, and for, the periods presented in this annual report;

4.*                *The registrant’s other certifyingofficer and I are responsible for establishing and maintaining disclosurecontrols and procedures (as defined in Exchange Act Rules 13a-14 and15d-14) for the registrant and have:

(a)          designed such disclosurecontrols and procedures , or caused such disclosure controls and procedures tobe designed under our supervision, to ensure that material information relatingto the registrant, including its consolidated subsidiaries, is made known to usby others within those entities, particularly during the period in which thisannual report is being prepared;

(b)*        *evaluated the effectiveness of theregistrant’s disclosure controls and procedures and presented in this reportour conclusions about the effectiveness of the disclosure controls andprocedures as of the end of the period covered by this report based on suchevaluation; and

(c)*         *disclosed in this report any change inthe registrant’s internal control over financial reporting that occurred duringthe registrant’s fourth fiscal quarter that has materially, affected, or isreasonably likely to materially affect, the registrant’s internal control overfinancial reporting.;

5.*                *The registrant’s other certifyingofficer and I have disclosed, based on our most recent evaluation of internalcontrol over financial reporting, to the registrant’s auditors and the auditcommittee of registrant’s board of directors (or persons performing theequivalent functions):

(a)*         *all significant deficiencies and materialweaknesses in the design or operation of internal control over financialreporting which are reasonably likely to adversely affect the registrant’sability to record, process, summarize and report financial information; and

(b)*        *any fraud, whether or not material, thatinvolves management or other employees who have a significant role in theregistrant’s internal controls over financial reporting.
| Dated: April 15, 2005 |     |
|----------------------------|----------|
| * *                   | * * | /s/  JANE E. SHAW, PH.D. |
| * *                   | * * | Jane  E. Shaw, Ph.D.*Chairman and Chief Executive Officer  (Principal Executive Officer)* |

 

----
Exhibit 13.1

                    PRINCIPAL EXECUTIVE OFFICER CERTIFICATION
                       PURSUANT TO 18 U.S.C. SECTION 1350

In connection with this Annual Report of Golden State Petro (IOM I-B) PLC (the
"Company") on Form 20-F for the annual period ended December 31, 2006, as filed
with the Securities and Exchange Commission (the "SEC") on or about the date
hereof (the "Report"), I, Tor Olav Troim, the Principal Executive Officer of the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)  The Report fully complies with the requirements of Section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

(2)  The information contained in the Report fairly presents, in all material
     respects, the financial condition and results of operations of the Company.

A signed original of this written statement has been provided to the Company and
will be retained by the Company and furnished to the SEC or its staff upon
request.

Date:   June 24, 2007



/s/ Tor Olav Troim
-----------------------------
    Tor Olav Troim
    Principal Executive Officer
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Consumer Product Safety Commission

# TIME AND DATE: 

                        Wednesday, January 15, 2025—10:00 a.m. (See                         **MATTERS TO BE CONSIDERED**                        )                    

# PLACE: 

Room 420, Bethesda Towers, 4330 East West Highway, Bethesda, MD.

# STATUS: 

Commission Meeting—Open to the public (10:00 a.m.); Closed Meeting will follow immediately after conclusion of the public meeting.

# MATTERS TO BE CONSIDERED:

      ( print page 2676)    

## Open Session

Briefing Matter on Notice of Proposed Rulemaking—Safety Standard for Lithium-Ion Batteries Micromobility Products

                    A live webcast of the meeting can be viewed at the following link:                     *https://events.gcc.teams.microsoft.com/​event/​7ba35e5b-216d-40a2-b183-9f382a696b3e@7f5de26c-a63d-475c-9b6c-4126a914e132*

Dial in by telephone: +1 469-676-2705, CODE,191380541#

## Closed Session

Briefing Matter

# CONTACT PERSON FOR MORE INFORMATION: 

Alberta E. Mills, Office of the Secretary, U.S. Consumer Product Safety Commission, 4330 East West Highway, Bethesda, MD 20814, 301-504-7479 (Office) or 240-863-8938 (Cell).

Dated: January 8, 2025

Alberta E. Mills,

Commission Secretary.

[FR Doc. 2025-00585 Filed 1-8-25; 11:15 am]

BILLING CODE 6355-01-P
J.D.G. v. DEPARTMENT OF HUMAN RESOURCES

2170041

Court of Civil Appeals of Alabama.

October 17, 2017

Transferred to Houston Cir. Ct. for trial de novo pursuant to Rule 28(D), Ala.R.Juv.P.
STATE of Louisiana v. John H. CARTWRIGHT

NO. 2018-K-1531

Supreme Court of Louisiana.

April 22, 2019

*303Denied.

WEIMER, J., would grant.
**EXHIBIT
      32.2**





**CERTIFICATION
      OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
      PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**





I,
      Elena
      Pochapski, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
      to
      Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of
      Siberian Energy Group Inc. on Form 10-QSB for the quarter ended June 30, 2007
      fully complies with the requirements of Section 13(a) or 15(d) of the Securities
      Exchange Act of 1934 and that information contained in such Form 10-QSB fairly
      presents in all material respects the financial condition and results of
      operations of Siberian Energy Group Inc.





By:/s/*Elena Pochapski*


Elena
      Pochapski


Chief Financial
      Officer


(Principal
      Accounting Officer)





August
      14, 2007
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Research Education Program (R25 Clinical Trial Not Allowed).                    

*Date:*                         January 24, 2025.                    

*Time:*                         1:00 p.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                              ( print page 1177)    

*Place:*                         National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G21A, Rockville, MD 20892 (Video Assisted Meeting).                    

*Contact Person:*                         Shiv A. Prasad, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G21A, Rockville, MD 20892,                         *shiv.prasad@nih.gov*, (240) 627-3219.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: January 2, 2025.

Victoria E. Townsend,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2025-00104 Filed 1-6-25; 8:45 am]

BILLING CODE 4140-01-P